drugset / Trial / NCT01357538

Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

NCT01357538 ↗

Phase 4 Completed 197 enrolled Ursapharm Arzneimittel GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.

Timeline

Start
2009-02
Primary completion
2009-07
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator bibrocathol Small molecule 2 % Topical

Indications